Validation of the French Version of the QASCI in Caregivers of Patients With COPD
VALQASCI
1 other identifier
observational
224
1 country
2
Brief Summary
This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD). The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill. This study is also justified by the fact that, although the QASCI has been validated in other languages and contexts, it is essential to linguistically and culturally adapt this tool for the French-speaking population. Validation in French is crucial to ensure the fidelity of the results obtained and the validity of the conclusions drawn from this instrument for caregivers of patients with COPD in France. In summary, this study addresses a specific need by contributing to the prevention of pathologies among caregivers. It enhances early detection and support for caregivers of patients with COPD while paving the way for future research on this often-overlooked population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedStudy Start
First participant enrolled
October 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
September 16, 2025
September 1, 2025
1.6 years
October 15, 2024
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of the translation of the long version of the QASCI questionnaire (measuring caregiver burden) from Portuguese to French after the translation-back translation stage.
Responses to the QASCI questionnaire (32 items rated from 1 to 5 leading to an overall score and 7 subscores) and comparison with responses to the ZBI (Zarit Burden Interview), HADS (Hospital Anxiety and Depression Scale), and WHOQOL-Bref (World Health Organization Quality of Life Instrument - Short Form).
baseline
Secondary Outcomes (1)
Assess the reliability of the translation of the long version of the QASCI questionnaire.
baseline and at day 15
Study Arms (1)
caregivers of patients with COPD
Interventions
Caregivers must reply to the French version of the QASCI questionnaire, the ZBI (Zarit Burden Interview) questionnaire, HADS (Hospital Anxiety and Depression Scale), and WHOQOL-Bref (World Health Organization Quality of Life Instrument - Short Form). After 15 days, they wil reply to the French version of the QASCI questionnaire (to asse the reliability).
Eligibility Criteria
Informal caregivers of patients with COPD
You may qualify if:
- Being a caregiver of a relative with COPD (according to the GOLD criteria).
- Being 18 years old or older.
- The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month).
- Being a family member of the patient or living with the patient.
- Being able to complete the French questionnaires.
- Non-opposition statement provided.
- Person under judicial protection (guardianship, curatorship, etc.)
- Refusal to participate
- The patient under the caregiver's care has experienced an exacerbation in the previous month
- The caregiver reports that the patient has cognitive impairments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Brestlead
- Centre Hospitalier des Pays de Morlaixcollaborator
Study Sites (2)
Chu Brest
Brest, 29609, France
Centre hospitalier de Morlaix
Morlaix, 29600, France
Related Publications (1)
Hipolito N, Martins S, Ruivo A, Flora S, Silva CG, Marques A, Brooks D, Cruz J. Construct validity and reliability of the Informal Caregiver Burden Assessment Questionnaire (QASCI) in caregivers of patients with COPD. Respir Med. 2022 Dec;205:107027. doi: 10.1016/j.rmed.2022.107027. Epub 2022 Oct 31.
PMID: 36343503BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Beaumont, PhD
Centre Hospitalier des Pays de Morlaix
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 15, 2024
First Posted
October 22, 2024
Study Start
October 22, 2024
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
June 15, 2026
Last Updated
September 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be available beginning three years and ending fifteen years following the final study report completion
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
All collected data that underlie results in a publication